The Immunological Effect of Il-17 and Il-6 on the Development of Autoimmune Disease: Systemic Lupus Erythematosus in Iraqi Patients
Background: Alterations in immune system balance and the production of autoantibodies that attack features inside cells are important hallmarks of systemic lupus erythematosus (SLE), a chronic autoimmune disease. SLE is a challenging form of things that range from immune system foul-ups, exterior forces, hormone influences and even genes that just make it more likely. B and T cells, along with antigen-presenting cells, drive much of that inflammation-making material, primarily IL-6 and IL-17. Both natural and acquired body guards get much to wound up in the sickness, Objective: Interleukin-6 and interleukin-17 contributes to systemic lupus erythematosus (SLE) pathogenesis and may serve as biomarkers of disease-associated inflammation. This study evaluated these cytokines and other inflammatory markers in patients with SLE and healthy controls. Methodology: The study included ninety individuals of both sexes, ranging in age from thirteen to seventy years. They were divided into two main groups: 40 (29 females and 11 males) were assigned as controls and 51 (39 females and 12 males) were assigned as SLE patients. The diagnosis of SLE was established through patient interviews and physical examination. A venipuncture was performed for blood collection, and three tubes were utilized for ESR measurement. Serum was obtained and centrifuged for CRP and RF assays. Cellular cytokines such as interleukin-6 and interleukin-17 were determined by ELISA. Results: The levels of IL-6 and IL-17 were significantly higher in SLE patients than those in healthy subjects. It shows that these things are very much related to how unwell and how active the disease Levels of Erythrocyte Sedimentation Rate) ESR (, C-Reactive Protein)CRP(Rheumatoid Factor)RF( in patients, and ANA all significantly enhanced. Results indicate that IL-17, mainly produced by Th17 cells, recruits’ neutrophils and induces more inflammatory cytokines increasing tissue damage, while IL-6 stimulates maturation of B-cells and production of autoantibodies. In addition, the current study confirmed that Systemic lupus erythematosus is more frequent in women. Conclusion: Elevated levels of IL-6 and IL-17 may be linked to inflammation associated with SLE and may serve as future therapeutic targets as well as diagnostic biomarkers. Additional research is required to determine their therapeutic potential and diagnostic utility.
Authors
- Marwah Sabah Altaiee
- Hayam Aziz Mohammed (ORCID: https://orcid.org/0000-0003-1844-2459)
- Muhannad Illayan Massadeh (ORCID: https://orcid.org/0000-0002-9519-8819)
- Teeba Fares Hadi
- Batol I. Dheeb
Institutions
- University of Baghdad (IQ)
- Hashemite University (JO)
- University of Samarra (IQ)
Publication Details
- Journal
- Journal of Biotechnology Research Center
- Published
- 2026-11-17
- DOI
- https://doi.org/10.24126/jobrc.2026.20.2.961
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00